# Acurx Pharmaceuticals, Inc.: Form S-1, filed Sep 14, 2022

- Company: [Acurx Pharmaceuticals, Inc.](/companies/acxp.md) (CIK 1736243)
- Form: S-1
- Filed: 2022-09-14
- Accepted by EDGAR: Sep 14, 2022, 16:06 ET
- Period: not reported
- Accession: 0001104659-22-100019
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1736243/000110465922100019/tm2225711d1_s1.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1736243/000110465922100019/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1736243/000110465922100019/tm2225711d1_s1.htm

Filed Sep 14, 2022.
Source: SEC EDGAR, the filing index for accession 0001104659-22-100019. Last ingested by Listed: Nov 14, 2026, 21:17 ET. No prices; not investment advice.
